Position:
Director, Medical Review, Clinical Safety (MD) at Daiichi Sankyo Japan
Location:
New York City Metropolitan Area, United States
Found email addresses for Parth Kansagra:
Found phone for Parth Kansagra:
Aug 2024 - Current
Jul 2024 - Aug 2024
Jan 2021 - Apr 2024
Jan 2019 - Jan 2021
Jan 2017 - Jan 2019
Their professional focus is Adverse Events, Advisory Boards, and Argus Safety across 3 core areas.
Doctor of Medicine - MD at American University of Antigua College of Medicine
What is Parth Kansagra's email address?
SignalHire found a verified business email address for Parth Kansagra: k*****h@daiichisankyo.com.What is Parth Kansagra's phone number?
SignalHire found a verified phone number for Parth Kansagra: +1-***-***-4048.How do I contact Parth Kansagra at Daiichi Sankyo Japan?
You can reach Parth Kansagra through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.What is Parth Kansagra's professional background?
Parth Kansagra has 9 years of professional experience. They have held roles including Associate Director Medical Review Physician, Senior Manager PV Services / Medical Reviewer Lead, and Product Safety Specialist at companies such as Moderna, Accenture, and Eisai US. Their education includes Doctor of Medicine - MD from American University of Antigua College of Medicine.Is Parth Kansagra's contact information up to date?
Yes. Parth Kansagra's SignalHire profile was last updated on 27 September 2024, reflecting their current position as Director, Medical Review, Clinical Safety (MD) at Daiichi Sankyo Japan in Tokyo, Japan.SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.